Sore throat (acute): antimicrobial prescribing: NICE guideline [NG84] – NICE

This guideline sets out an antimicrobial prescribing strategy for acute sore throat. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sore throat is often caused by a virus, lasts for about a week, and most people get

Lenvatinib with everolimus for previously treated advanced renal cell carcinoma: Technology appraisal guidance [TA498] – NICE

Evidence-based recommendations on lenvatinib (Kisplyx) with everolimus for previously treated advanced renal cell carcinoma in adults.

Glecaprevir–pibrentasvir for treating chronic hepatitis C: Technology appraisal guidance [TA499] – NICE

Evidence-based recommendations on glecaprevir–pibrentasvir (Maviret) for treating chronic hepatitis C in adults.

Ceritinib for untreated ALK-positive non-small-cell lung cancer: Technology appraisal guidance [TA500] – NICE

Evidence-based recommendations on ceritinib (Zykadia) for untreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer in adults.

NHS and social care data: off-shoring and the use of public cloud services – NHS Digital

Guidance from NHS Digital setting clear expectations for health and care organisations who want to use cloud services or data offshoring to store patient information.  The guidance ensures that organisations know how to use these solutions safely and securely, especially in

Age-related macular degeneration: NICE guideline [NG82] – NICE

This guideline covers diagnosing and managing age-related macular degeneration (AMD) in adults. It aims to improve the speed at which people are diagnosed and treated to prevent loss of sight.

Sepsis guidance implementation advice for adults – NHS England

This document describes an operational definition of sepsis and supports the implementation of the NICE guidelines on the identification and treatment of sepsis.

Implementing Better Births: Continuity of Care – NHS England

This document provides practical guidance to Local Maternity Systems on how to improve their services so that women experience continuity in the clinicians providing their maternity care.

Autism spectrum disorder in under 19s: recognition, referral and diagnosis: Clinical guideline [CG128] – NICE

This guideline covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years. It also covers referral. It aims to improve the experience of children, young people and those who care for them. In

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point of care coagulometers (the CoaguChek XS system): Diagnostics guidance [DG14] – NICE

NICE has assessed 2 point-of care coagulometers to help the NHS decide whether to use these products. They are called CoaguChek XS and InRatio2 PT/INR. The INRatio2 PT/INR was withdrawn from the market in October 2016 and is not currently

Transvaginal mesh repair of anterior or posterior vaginal wall prolapse: Interventional procedures guidance [IPG599]

Evidence-based recommendations on transvaginal mesh repair of anterior or posterior vaginal wall prolapse. This involves inserting a mesh to replace tissue that has weakened and caused the pelvic organs to drop down (prolapse) into the vagina. This guidance replaces NICE interventional

Endobronchial valve insertion to reduce lung volume in emphysema: Interventional procedures guidance [IPG600] – NICE

Evidence-based recommendations on endobronchial valve insertion to reduce lung volume in emphysema. This involves placing small one-way valves in some airways leading to damaged parts of the lungs. This guidance replaces NICE interventional procedures guidance on insertion of endobronchial valves for

Transcutaneous microwave ablation for severe primary axillary hyperhidrosis: Interventional procedures guidance [IPG601] – NICE

Evidence-based recommendations on transcutaneous microwave ablation for severe primary axillary hyperhidrosis in adults. This involves using microwaves to destroy sweat glands in the armpit.

Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure: Interventional procedures guidance [IPG602] – NICE

Evidence-based recommendations on artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. This involves replacing the 2 lower chambers of the heart with a mechanical device to improve circulation until heart transplantation.

Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death: Interventional procedures guidance [IPG603] – NICE

Evidence-based recommendations on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. This involves placing a device under the skin of the chest, which detects and treats fast heartbeats called tachyarrhythmias. This guidance replaces NICE interventional procedures guidance on insertion

Human Animal Infections and Risk Surveillance (HAIRS) group: Qualitative assessment of the risk that West Nile virus presents to the UK human population

West Nile virus infections have long been recognised in Europe where there is annual surveillance for human and equine disease. In the USA, large numbers of human infections were recorded annually following its introduction in 1999, and it is now

A brief guide to Section 136 for Emergency Departments – Royal College of Emergency Medicine

This guide outlines the process to be followed when police bring a person to the Emergency Department under a section136 of the Mental Health Act and the responsibilities of the different agencies caring for the person.  It notes the main change detailed

Suspected cancer: Quality standard [QS124] – NICE

This quality standard covers the investigation and recognition of suspected cancer, and referral to specialist cancer services for adults, young people and children. It describes high-quality care in priority areas for improvement. In December 2017, the source guidance and definitions

Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease: Medtech innovation briefing [MIB132] – NICE

NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease.  It identifies the costs of this technology in addition to identifying the impacts on patients and the Health

Interim Public Health Operational Guidelines for Amoebiasis (Entamoeba histolytica) – Public Health England

This guideline supports public health practitioners, environmental health officers and healthcare professionals to manage cases of E. histolytica infection and provide appropriate public health advice.